Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
   
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Hep C 3a
Jun 5, 2007

Hello,

I was recently, (1 year) diagnosed with Hepatitis C genotype 3a. I have probably been infected for 20 years so far. I am not having any major side effects so far while I am doing my treatment with interferon and rivarbirin. What do you think are my chances for SVR and have there been any long term studies as far to how long has someone with SVR has gone without a relapse?

Thank you

Response from Dr. McGovern

You should do quite well. I would predict about a 65-70 percent chance of clearing. However, if your virus clears in 4 weeks after starting treatment, there are data that suggest that the chance of a sustained virologic response (SVR) are even higher in those who rapidly clear.

It is also critical to take all your medications.

Yes, there are data to suggest that those who attain a SVR do not relapse.



Previous
Help...asian!!
Next
Hepatitis A

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement